MEREDITH BARLOW: Open Payments
NPI 1962821637 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$590 in 31 payments from 15 companies in 2025. Trend: 2023 $46 · 2024 $447 · 2025 $590
Food & beverage: $590
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $153 |
| Amgen Inc. | 4 | $78 |
| Aimmune Therapeutics, Inc. | 3 | $53 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
| Astellas Pharma US Inc | 1 | $33 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| PFIZER INC. | 2 | $31 |
| Lilly USA, LLC | 2 | $28 |
| CooperSurgical, Inc. | 1 | $22 |
Products named: BREZTRI, EVENITY, ZENPEP, REXULTI, JARDIANCE, Veozah, SHINGRIX, MOUNJARO.
Industry payments across NM — which companies pay providers there.
